Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.81 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.65 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6553283 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL6372057 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL6730310 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL6372065 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL17204255 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494096 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494095 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL21998924 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494097 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9716614 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-03-06 | — | — | US | claimed |
| EP-4378921-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (CN) | 2024-06-05 | — | — | EP | claimed |
| US-20210106661-A1 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-04-15 | — | — | US | claimed |
| EP-3368157-A2 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | Dana-Farber Cancer Institute, Inc. (US) | 2018-09-05 | — | — | EP | claimed |
| WO-2017075329-A2 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-05-04 | — | — | WO | claimed |
| US-3969087-A | Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents | AJINOMOTO CO., LTD. (JA) | 1976-07-13 | — | — | US | claimed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-03-06 | — | — | US | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| US-12194080-B2 | Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| WO-2024165426-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-15 | — | — | WO | disclosed |
| EP-4414360-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| EP-3368157-A2 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | Dana-Farber Cancer Institute, Inc. (US) | 2018-09-05 | — | — | EP | disclosed |
| US-20180215703-A1 | STEAROYL AMINO ACID SALT AND METHOD OF USE THEREOF | SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE (CN) | 2018-08-02 | — | — | US | disclosed |
| US-9914698-B2 | Stearoyl amino acid salt and preparation method and application thereof | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2018-03-13 | — | — | US | disclosed |
| WO-2017075329-A2 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20160326096-A1 | STEAROYL AMINO ACID SALT AND PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2016-11-10 | — | — | US | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | FABP2, FABP1, FASN | FAAH 204/4885ITGB3 4133/4885ITGA2B 2873/4885 |
| US-20180215703-A1 | STEAROYL AMINO ACID SALT AND METHOD OF USE THEREOF | BCAT2, BCAT1, SLC1A2 | FAAH 778/4885ITGB3 4402/4885ITGA2B 3768/4885 |
| US-20160326096-A1 | STEAROYL AMINO ACID SALT AND PREPARATION METHOD AND APPLICATION THEREOF | SLC7A1, SLC1A5, SLC27A1 | FAAH 32/4885ITGB3 4614/4885ITGA2B 4242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.